Select status:
Sort by:
Filter by expected publication date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and July 2024

Filter by type
Showing 1 to 10 of 511
Title Type Expected publication date
Axitinib, everolimus, sorafenib and sunitinib for treated advanced or metastatic renal cell carcinoma [ID897] Technology appraisal guidance Expected publication date:TBC 0
Abdominal aortic aneurysm: diagnosis and management NICE guideline Expected publication date:TBC 0
Abemaciclib for treating KRAS mutation-positive non-small-cell lung cancer after platinum-based chemotherapy ID1147 Technology appraisal guidance Expected publication date:TBC 0
Abemaciclib monotherapy for treating advanced hormone-receptor positive, HER2-negative breast cancer after endocrine therapy and chemotherapy ID1347 Technology appraisal guidance Expected publication date:TBC 0
Abiraterone for treating newly diagnosed high risk metastatic hormone-naive prostate cancer [ID945] Technology appraisal guidance Expected publication date:TBC 0
Acalabrutinib for Chronic Lymphocytic Leukaemia (CLL)in Elderly and unfit patients, Not specified, First line [ID1614] Technology appraisal guidance Expected publication date:TBC 0
Acalabrutinib for previously treated chronic lymphocytic leukaemia [ID1613] Technology appraisal guidance Expected publication date:TBC 0
Acne Vulgaris: Management NICE guideline Expected publication date:13 January 2021 20210113
Acute coronary syndromes NICE guideline Expected publication date:14 May 2020 20200514
Acute kidney injury: prevention, detection and management (update) NICE guideline Expected publication date:08 July 2020 20200708